These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10692716)

  • 1. Defining optimal dosing for sumatriptan tablets in the acute treatment of migraine.
    Mathew NT; Salonen R
    Int J Clin Pract Suppl; 1999 Aug; 105():2-6. PubMed ID: 10692716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
    Salonen R; Ashford EA; Gibbs M; Hassani H
    Int J Clin Pract Suppl; 1999 Aug; 105():16-24. PubMed ID: 10692718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Sumatriptan Tablets S2CM10 Study Group.
    Dowson AJ; Ashford EA; Prendergast S; Hassani H; Roberts GW; Flöter T; Szczudlik A
    Int J Clin Pract Suppl; 1999 Aug; 105():25-33. PubMed ID: 10692719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
    Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-defining study of sumatriptan suppositories in the acute treatment of migraine.
    Bertin L; Brion N; Färkkilä M; Göbel H; Wessely P
    Int J Clin Pract; 1999 Dec; 53(8):593-8. PubMed ID: 10692752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixing sumatriptan: a prospective study of stratified care using multiple formulations.
    Kaniecki RG
    Headache; 2001 Oct; 41(9):862-6. PubMed ID: 11703472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines.
    Friedman BW; Hochberg M; Esses D; Bijur PE; Corbo J; Paternoster J; Solorzano C; Toosi B; Lipton RB; Gallagher EJ
    Headache; 2006 Jun; 46(6):934-41. PubMed ID: 16732839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials.
    Tfelt-Hansen P; Ryan RE
    Neurology; 2000; 55(9 Suppl 2):S19-24. PubMed ID: 11089515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger.
    Hämäläinen M; Jones M; Loftus J; Saiers J
    Int J Clin Pract; 2002 Nov; 56(9):704-9. PubMed ID: 12469987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
    Natarajan S; Jabbour JT; Webster CJ; Richardson MS
    Headache; 2004; 44(10):969-77. PubMed ID: 15546259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic treatment of acute migraine attack in children].
    Cuvellier JC; Joriot S; Auvin S; Vallée L
    Arch Pediatr; 2005 Mar; 12(3):316-25. PubMed ID: 15734131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fixed-dose combination of sumatriptan and naproxen for migraine.
    Med Lett Drugs Ther; 2008 Jun; 50(1288):45-6. PubMed ID: 18551089
    [No Abstract]   [Full Text] [Related]  

  • 19. Zolmitriptan: new product. Similar to sumatriptan.
    Prescrire Int; 1999 Apr; 8(40):41-3. PubMed ID: 10848058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.